Main > INFECTIOUS DISEASES > JP. T. PostTransplant CMV>Treat.>

---

JP. T. PostTransplant CMV>Treat.>'s subsections
(*) USA Approval Date: 2021. 11.24
>Benzimidazole Riboside Oral
Company
Generic Name: Maribavir
Patent>Assignee; Claims; No.; Etc.
Patent>Total USA No.: 4
Patent>UpDate: 2021. 11.23
PR Web-Site

JP. T. PostTransplant CMV>Treat.>'s products
This section has no products